Leukopoietics

Leukopoietics are therapeutic agents designed to stimulate the production of white blood cells, particularly neutrophils, in patients experiencing bone marrow suppression or immune deficiency. These drugs include recombinant granulocyte colony-stimulating factors (G-CSFs), granulocyte–macrophage colony-stimulating factors (GM-CSFs), and other hematopoietic modulators. They function by promoting proliferation, differentiation, and activation of precursor cells within the bone marrow, thereby accelerating recovery from neutropenia induced by chemotherapy, radiation therapy, or congenital disorders. Leukopoietics reduce the risk of severe infections, shorten hospital stays, and enable continuation of dose-intensive cancer therapies. Although generally effective and well tolerated, they may cause bone pain, splenomegaly, or rare hematologic complications, requiring periodic monitoring. These agents are essential in supportive oncology and hematology, helping maintain immune resilience in vulnerable patients.